LAURUS LABS LIMITED vs LUPIN LIMITED

A side-by-side comparison of LAURUS LABS LIMITED (LAURUSLABS) and LUPIN LIMITED (LUPIN) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, LUPIN LIMITED leads LAURUSLABS vs LUPIN on 13 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation04
  • Profitability04
  • Growth02
  • Size & financial health13
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

LUPIN takes 4/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

125.08
P/E ratio
16.80
19.74
P/B ratio
4.23
0.10%
Dividend yield
0.87%
₹16.47
EPS
₹116.75

Profitability

LUPIN takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

16.77%
Return on equity
23.76%
17.58%
Return on capital
25.14%
26.09%
EBITDA margin
31.53%
13.07%
Net margin
19.16%

Growth

LUPIN takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

4.09%
Revenue CAGR (3Y)
18.88%
3.91%
Profit CAGR (3Y)
128.70%

Size & financial health

LUPIN takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.11L Cr
Market cap
₹89,702 Cr
₹6,813 Cr
Revenue
₹27,958 Cr
₹890 Cr
Net profit
₹5,355 Cr
0.45
Debt / equity
0.29
LAURUS LABS LIMITED
  • + []
  • − ["Stock is trading at 21.00 times its book value", "The company has delivered a poor sales growth of 7.2% over past five years.", "The company has delivered a poor profit growth of -2.0% over past five years."]
LUPIN LIMITED
  • + ["Company has delivered good profit growth of 34.3% CAGR over last 5 years", "Company has a good return on equity (ROE) track record: 3 Years ROE 20.8%"]
  • − []
LAURUS LABS LIMITED full analysis LUPIN LIMITED full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.